iRhythm Technologies Inc

More Details of iRhythm Technologies Inc Company

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Company Info

Company codeIRTC

Company nameiRhythm Technologies Inc

IPO dateOct 20, 2016

Founded at2006

CEOMr. Quentin S. Blackford

Number of employees2000

Security typeOrdinary Share

Fiscal year-endOct 20

Address699 8th Street

CitySAN FRANCISCO

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited States of America

Postal code94103

Phone14156325700

Websitehttps://www.irhythmtech.com/

Company codeIRTC

IPO dateOct 20, 2016

Founded at2006

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Quentin S. Blackford

President, Chief Executive Officer, Director

107.06K

-1.92%

Ms. Sumi Shrishrimal

Executive Vice President, Chief Risk Officer

35.86K

-4.59%

Mr. Daniel G. (Dan) Wilson

Chief Financial Officer

22.70K

+9.32%

Mr. Abhijit Y. (Abhi) Talwalkar

Independent Chairman of the Board

17.10K

-2.54%

Mr. Mervin Smith

Executive Vice President - Business Operations

16.45K

-3.73%

Dr. Minang (Mintu) Turakhia, M.D.

Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer

13.66K

-27.46%

Dr. Ralph Snyderman, M.D.

Independent Director

10.09K

-4.22%

Mr. Bruce G. Bodaken

Independent Director

9.44K

-4.50%

Ms. Mojdeh Poul

Independent Director

800.00

-81.13%

Mr. Chad M. Patterson

Chief Commercial Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Quentin S. Blackford

President, Chief Executive Officer, Director

107.06K

-1.92%

Ms. Sumi Shrishrimal

Executive Vice President, Chief Risk Officer

35.86K

-4.59%

Mr. Daniel G. (Dan) Wilson

Chief Financial Officer

22.70K

+9.32%

Mr. Abhijit Y. (Abhi) Talwalkar

Independent Chairman of the Board

17.10K

-2.54%

Mr. Mervin Smith

Executive Vice President - Business Operations

16.45K

-3.73%

Dr. Minang (Mintu) Turakhia, M.D.

Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer

13.66K

-27.46%

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Commercial Payors

311.61M

52.65%

Contracted third-party payors

311.61M

52.65%

Centers for Medicare & Medicaid

142.39M

24.06%

Healthcare Institutions

95.11M

16.07%

Non-contracted third-party payors

42.73M

7.22%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Commercial Payors

311.61M

52.65%

Contracted third-party payors

311.61M

52.65%

Centers for Medicare & Medicaid

142.39M

24.06%

Healthcare Institutions

95.11M

16.07%

Non-contracted third-party payors

42.73M

7.22%

Shareholder

Update time: Sun, Feb 23

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

Sands Capital Management, LLC

9.95%

The Vanguard Group, Inc.

9.80%

Artisan Partners Limited Partnership

8.66%

BlackRock Institutional Trust Company, N.A.

7.44%

Capital Research Global Investors

5.13%

Other

59.02%

Shareholder Statistics

Shareholder

Proportion

Sands Capital Management, LLC

9.95%

The Vanguard Group, Inc.

9.80%

Artisan Partners Limited Partnership

8.66%

BlackRock Institutional Trust Company, N.A.

7.44%

Capital Research Global Investors

5.13%

Other

59.02%

Type

Shareholder

Proportion

Investment Advisor

57.82%

Investment Advisor/Hedge Fund

34.63%

Hedge Fund

9.32%

Research Firm

4.46%

Family Office

1.80%

Individual Investor

1.15%

Bank and Trust

0.94%

Pension Fund

0.89%

Sovereign Wealth Fund

0.45%

Institutional Shareholding

Update time: Tue, Mar 4

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

557

35.33M

112.50%

-4.26M

2024Q4

571

35.12M

111.82%

-4.41M

2024Q3

584

35.86M

114.62%

-4.91M

2024Q2

581

36.60M

117.28%

-2.20M

2024Q1

578

35.68M

114.75%

-1.24M

2023Q4

542

34.05M

110.03%

-1.99M

2023Q3

543

34.13M

111.64%

-2.86M

2023Q2

537

34.27M

112.49%

-3.29M

2023Q1

552

34.64M

113.74%

-3.49M

2022Q4

590

31.46M

104.50%

-5.82M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Sands Capital Management, LLC

3.18M

10.11%

+33.65K

+1.07%

Dec 31, 2024

The Vanguard Group, Inc.

3.13M

9.96%

+18.44K

+0.59%

Dec 31, 2024

Artisan Partners Limited Partnership

2.76M

8.8%

-17.52K

-0.63%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

2.37M

7.56%

+88.94K

+3.89%

Dec 31, 2024

Capital Research Global Investors

1.64M

5.21%

-317.97K

-16.26%

Dec 31, 2024

Mackenzie Investments

1.38M

4.4%

-37.89K

-2.67%

Dec 31, 2024

State Street Global Advisors (US)

948.78K

3.02%

+39.94K

+4.39%

Dec 31, 2024

BNP Paribas Asset Management USA, Inc.

860.81K

2.74%

+179.74K

+26.39%

Dec 31, 2024

Westfield Capital Management Company, L.P.

765.25K

2.44%

+236.96K

+44.85%

Dec 31, 2024

Eventide Asset Management, LLC

739.41K

2.35%

+2.69K

+0.36%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

Global X Telemedicine & Digital Health ETF

4.07%

BNY Mellon Innovators ETF

2.44%

Fidelity Digital Health ETF

1.93%

SPDR S&P Health Care Equipment ETF

1.57%

ROBO Global Healthcare Technology & Innovation ETF

1.37%

Harbor Health Care ETF

1.22%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.17%

Goldman Sachs Future Health Care Equity ETF

1.15%

SPDR S&P Kensho New Economies Composite ETF

0.85%

JPMorgan Fundamental Data Science Small Core ETF

0.74%

Global X Telemedicine & Digital Health ETF

Proportion4.07%

BNY Mellon Innovators ETF

Proportion2.44%

Fidelity Digital Health ETF

Proportion1.93%

SPDR S&P Health Care Equipment ETF

Proportion1.57%

ROBO Global Healthcare Technology & Innovation ETF

Proportion1.37%

Harbor Health Care ETF

Proportion1.22%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proportion1.17%

Goldman Sachs Future Health Care Equity ETF

Proportion1.15%

SPDR S&P Kensho New Economies Composite ETF

Proportion0.85%

JPMorgan Fundamental Data Science Small Core ETF

Proportion0.74%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

106.640USD

iRhythm Technologies Inc

106.640

Overview

Company